GEMCOVAC™-19
Gennova’s mRNA vaccine, GEMCOVAC™-19, which is stable at 2-8°C,
has received the Emergency Use Authorization (EUA)
GEMCOVAC™-19
Gennova’s mRNA vaccine, GEMCOVAC™-19, which is stable at 2-8°C,
has received the Emergency Use Authorization (EUA)